Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROTHENA CORP PUBLIC LTD CO Director's Dealing 2017

Mar 1, 2017

32782_dirs_2017-03-01_27d1f856-2bc1-456b-bcee-6375827222fe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2017-02-27

Reporting Person: HENNEY CHRISTOPHER S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-27 Ordinary Shares, par value $0.01 per share M 5989 $6.65 Acquired 5989 Direct
2017-02-27 Ordinary Shares, par value $0.01 per share S 5989 $57.1632 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-27 Stock Option
(right to buy) $6.65 M 5989 Disposed 2023-03-18 Ordinary Shares (5989) Direct

Footnotes

F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.

F2: The transaction was executed in multiple trades in prices ranging from $57.00 to $57.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F3: The shares subject to the option are fully vested and exercisable as of the date hereof.